Cell-penetrating peptides: breaking through to the other side.
暂无分享,去创建一个
[1] V. Torchilin. Tat Peptide-modified Liposomes for Intracellular Delivery of Drugs and Dna , 2022 .
[2] S. Kelley,et al. Cell-penetrating peptides as delivery vehicles for biology and medicine. , 2008, Organic & biomolecular chemistry.
[3] Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency. , 2012, Biomaterials.
[4] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[5] F. Hudecz,et al. Medium‐sized peptides as built in carriers for biologically active compounds , 2005, Medicinal research reviews.
[6] V. Torchilin,et al. “Smart” Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes , 2007, Journal of liposome research.
[7] Xin-guo Jiang,et al. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo. , 2010, Human gene therapy.
[8] S. Futaki,et al. Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.
[9] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[10] H. Merkle,et al. Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. , 2005, Biophysical journal.
[11] Shiroh Futaki,et al. Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[12] S. Henriques,et al. Translocation or membrane disintegration? Implication of peptide–membrane interactions in pep‐1 activity , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[13] Simon C Watkins,et al. Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran Sulfate* , 2002, The Journal of Biological Chemistry.
[14] M. Pooga,et al. Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] Vishal Sharma. LIPOSOMES IN DRUG DELIVERY SYSTEM: A REVIEW , 2013 .
[16] V. Torchilin,et al. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] Vladimir P Torchilin,et al. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Rothbard,et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.
[19] Ülo Langel,et al. Handbook of cell-penetrating peptides , 2006 .
[20] S. Barcikowski,et al. Penetratin-Conjugated Gold Nanoparticles − Design of Cell-Penetrating Nanomarkers by Femtosecond Laser Ablation , 2011 .
[21] V. Torchilin,et al. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. , 2006, Bioconjugate chemistry.
[22] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[23] A A Bogdanov,et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.
[24] K. Jeang,et al. Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.
[25] Xiaoping P. Hu,et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent , 2004, JBIC Journal of Biological Inorganic Chemistry.
[26] M. Giacca,et al. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. , 2004, The Journal of biological chemistry.
[27] Vladimir P Torchilin,et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo , 2005, Nature Medicine.
[28] Weihong Tan,et al. TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. , 2004, Chemical communications.
[29] R. Hancock,et al. Histones and Basic Polyamino Acids Stimulate the Uptake of Albumin by Tumor Cells in Culture , 1965, Science.
[30] Ulo Langel,et al. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. , 2005, Advanced drug delivery reviews.
[31] Joseph Rosenecker,et al. Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo , 2004, Pharmaceutical Research.
[32] Ű. Langel,et al. Therapeutic delivery opportunities, obstacles and applications for cell-penetrating peptides. , 2011, Therapeutic delivery.
[33] R Weissleder,et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.
[34] Christoph Patsch,et al. The FASEB Journal Research Communication Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells , 2022 .
[35] M. Mano,et al. Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems , 2010, Pharmaceuticals.
[36] Vladimir P Torchilin,et al. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. , 2009, International journal of pharmaceutics.
[37] Maria Lindgren,et al. Classes and prediction of cell-penetrating peptides. , 2011, Methods in molecular biology.
[38] V. Torchilin,et al. Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements , 2011, Drug delivery.
[39] B. Lebleu,et al. Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors* , 2005, Journal of Biological Chemistry.
[40] Hideyoshi Harashima,et al. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. , 2011, Advanced drug delivery reviews.
[41] R. Brock,et al. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner. , 2011, Chemistry & biology.
[42] I. Aoki,et al. Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy. , 2011, Biomaterials.
[43] Vladimir P Torchilin,et al. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[44] D. A. Stein,et al. Cell penetrating peptide conjugates of steric block oligonucleotides☆ , 2007, Advanced Drug Delivery Reviews.
[45] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[46] R. Patlolla,et al. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery , 2010, Molecular membrane biology.
[47] Steven F Dowdy,et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.
[48] Vladimir P. Torchilin,et al. Multifunctional pharmaceutical nanocarriers , 2008 .
[49] W. Seeger,et al. Effects of cell‐penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs , 2008, The journal of gene medicine.
[50] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[51] G. Elliott,et al. Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.
[52] M. Green,et al. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. , 1988, Cell.
[53] Y. Tseng,et al. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.
[54] Yao Qin,et al. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration. , 2011, Molecular pharmaceutics.
[55] S. Futaki,et al. Delivery of Macromolecules Using Arginine-Rich Cell-Penetrating Peptides: Ways to Overcome Endosomal Entrapment , 2009, The AAPS Journal.
[56] V. Torchilin,et al. Environment-responsive multifunctional liposomes. , 2010, Methods in molecular biology.
[57] Vladimir P Torchilin,et al. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. , 2008, Biopolymers.
[58] Sandra L. Schmid,et al. Regulated portals of entry into the cell , 2003, Nature.
[59] Juan B. Blanco-Canosa,et al. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size. , 2011, ACS nano.
[60] Shuming Nie,et al. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. , 2008, Journal of the American Chemical Society.
[61] R. Juliano,et al. Intracellular Delivery of Oligonucleotide Conjugates and Dendrimer Complexes , 2006, Annals of the New York Academy of Sciences.
[62] B. Wiesner,et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.
[63] M. Ferrer,et al. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. , 2005, Biochimica et biophysica acta.
[64] V. Torchilin,et al. TAT peptide and its conjugates: proteolytic stability. , 2009, Bioconjugate chemistry.
[65] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[66] Vladimir P Torchilin,et al. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. , 2005, Advanced drug delivery reviews.
[67] Vladimir P Torchilin,et al. Enhanced transfection of tumor cells in vivo using “Smart” pH-sensitive TAT-modified pegylated liposomes , 2007, Journal of drug targeting.
[68] Vladimir P Torchilin,et al. TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice. , 2006, Oncology research.
[69] Isabelle Tranchant,et al. DTS-108, A Novel Peptidic Prodrug of SN38: In vivo Efficacy and Toxicokinetic Studies , 2008, Clinical Cancer Research.
[70] Steven F Dowdy,et al. Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[71] J. Méry,et al. The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. , 1995, Biochemical and biophysical research communications.
[72] Y. Negishi,et al. Bubble liposomes and ultrasound promoted endosomal escape of TAT-PEG liposomes as gene delivery carriers. , 2011, Molecular pharmaceutics.
[73] Rainer Fischer,et al. A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.
[74] H. Okada,et al. Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration , 2011, Pharmaceutical Research.
[75] G. Tang,et al. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine. , 2011, Biomaterials.
[76] A. Prochiantz,et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.
[77] Vladimir Torchilin,et al. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[78] Jannik N. Andersen,et al. Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.
[79] T. Tarragó,et al. all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study. , 2007, Biochemical Society transactions.
[80] V. Torchilin. Liposomes in Drug Delivery , 2012 .
[81] PTD-DRBD siRNA delivery. , 2011, Methods in molecular biology.
[82] Vladimir P Torchilin,et al. Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.